BridgeBio Pharma

YTD

ALL

Trade BridgeBio Pharma 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BBIO

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development.

CEO

Neil Kumar

CEONeil Kumar

Employees

730

Employees730

Headquarters

Palo Alto, California

HeadquartersPalo Alto, California

Founded

2015

Founded2015

Employees

730

Employees730

BBIO Key Statistics

Market cap

10.50B

Market cap10.50B

Price-Earnings ratio

-13.41

Price-Earnings ratio-13.41

Dividend yield

—

Dividend yield—

Average volume

2.00M

Average volume2.00M

High today

$55.49

High today$55.49

Low today

$54.02

Low today$54.02

Open price

$54.38

Open price$54.38

Volume

1.36M

Volume1.36M

52 Week high

$57.49

52 Week high$57.49

52 Week low

$21.72

52 Week low$21.72

BBIO News

Nasdaq 1d

Interesting BBIO Put And Call Options For December 19th

Investors in BridgeBio Pharma Inc (Symbol: BBIO) saw new options begin trading this week, for the December 19th expiration. At Stock Options Channel , our Yield...

Analyst ratings

95%

of 20 ratings

Buy

95%

Hold

Sell

People also own

Based on the portfolios of people who own BBIO. This list is generated using Robinhood data, and it’s not a recommendation.

Taiwan Semiconductor Manu…